Literature DB >> 28684698

Synthesis and Fungicidal Activity of 1-(Carbamoylmethyl)-2-aryl-3,1-benzoxazines.

Zi-Long Tang1,2, Lian Wang3,4, Jing-Zhao Tan5,6, Yi-Chao Wan7, Yin-Chun Jiao8.   

Abstract

A series of new 1-(carbamoylmethyl)-2-aryl-3,1-benzoxazines were prepared in moderate to good yields by BF₃·OEt₂-catalyzed reactions of aromatic aldehydes with 2-(N-substituted carbamoylmethylamino)benzyl alcohols. The structures of the target compounds were confirmed by IR, ¹H-NMR, 13C-NMR, and elemental analyses. The fungicidal activities of the target compounds against plant fungi were preliminarily evaluated, and some of them exhibited good activity.

Entities:  

Keywords:  BF3·OEt2; disubstituted-3,1-benzoxazine; fungicidal activity; heterocycles; synthesis

Mesh:

Substances:

Year:  2017        PMID: 28684698      PMCID: PMC6152388          DOI: 10.3390/molecules22071103

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

3,1-Benzoxazine and 3,1-benzoxazinone derivatives have received growing attention due to their broad biological activities. 3,1-Benzoxazine derivatives show anticonvulsant [1], herbicidal [2], fungicidal [3,4], and anticancer activity [5], and some are potent progesterone receptor (PR) agonists [6] or DNA-binding antitumor agents [7]. 3,1-Benzoxazinones exhibit antihypertensive [8] and antiproliferative activities [9], or are potent PR agonists/antagonists [10,11], potent human leukocyte elastase inhibitors [12], serine protease inhibitors [13,14,15], long chain fatty acid elongase 6 inhibitors [16], NK1/NK3 receptor antagonists [17], α-chymotrypsin inhibitors [18], mineralocorticoid receptors antagonists [19], and are even used as anti-HIV-1 reverse transcriptase inhibitors [20,21]. Therefore, the synthesis of 3,1-benzoxazines and 3,1-benzoxazinone has attracted considerable interest. The condensation of 2-aminobenzyl alcohol or its derivatives with aldehydes using acetic acid or p-toluenesulfonic acid (TsOH) as catalyst is the widely-used way to synthesize 3,1-benzoxazines [6,22,23]. Palladium-catalyzed cyclization of 2-alkynylanilides also provides a route to substituted 3,1-benzoxazines [24]. Recently, hypervalent iodine-mediated oxygenation of tertiary amines afforded a new way [25]. As for 3,1-benzoxazinones, the frequently used protocol is the reaction of 2-aminobenzyl alcohol or its derivatives with phosgene [8,26]. More recently, silver-catalyzed incorporation of carbon dioxide into 2-alkynylanilides afforded a new route [27]. In spite of the progress in their preparation, the development of more efficient ways and the synthesis of novel 3,1-benzoxazine derivatives are still highly desirable for drug discovery, as well as medicinal and pesticide chemistry. To our knowledge, 3,1-benzoxazines have received less attention compared with 3,1-benzoxazinones. Particularly, there are only few reports about the activities of benzoxazines against plant fungi [3,4]. Thus, we present herein the synthesis of novel 1-(carbamoylmethyl)-2-aryl-3,1-benzoxazines, as a continuation of our ongoing project aimed at searching for novel fungicidal active compounds, by condensation reactions of 2-(N-substituted carbamoylmethylamino)benzyl alcohols with aldehydes in the presence of BF3·OEt2, and also report their fungicidal activities against plant fungi.

2. Results and Discussion

2.1. Chemistry

The synthetic route to the title compounds 5a–r is shown in Scheme 1. The key intermediate 2-(N-substituted carbamoylmethylamino)benzyl alcohols 3 (also named as: N-substituted 2-(2-(hydroxymethyl)phenylamino)acetamide) were prepared by selective N-alkylation of 2-aminobenzyl alcohol with N-substituted 2-bromoacetamide 2. The reaction exclusively occurred at the nitrogen atom giving products 3a–f (1H-NMR and 13C-NMR Data in Supplementary materials) in 65–73% yields when the reaction was carried out in a mixture solvent of N,N-dimethyl formamide (DMF) and tetrahydrofuran (THF) (v/v = 1:2) with potassium carbonate as base. Then, we began to synthesize the target products 5a–r (1H-NMR and 13C-NMR Data in Supplementary materials). The preparation of 5a was selected as model to optimize the reaction conditions. Firstly, reaction of 2-(N-(2-methylphenyl)carbamoylmethylamino)benzyl alcohol 3a with 3-nitrobenzaldehyde 4a in the presence of BF3·OEt2 (10% mol) in THF under 65 °C gave the desired product 5a in 35 yields (No. 1, Table 1). By optimizing the conditions, the yield was improved to 55% (No. 6). Under the same conditions, compounds 5b–r were synthesized in 40–85% yields. As shown in Table 1, for compounds with an amide nitrogen connected to the benzyl group, a higher yield was achieved than for those with a phenyl group (No. 16–18 vs. No. 13–15, Table 1), and moreover, the reaction yields of the former depended on the position of the nitro group on the benzene ring in order of para > ortho > meta. But, the yields for those with an amide nitrogen connected with an aryl group presented the order of meta > para > ortho.
Scheme 1

Synthesis of 1-(carbamoylmethyl)-2-aryl-3,1-benzoxazines 5.

Table 1

The results of the preparation of 3,1-benzoxazines 5a a.

No.RR1ConditionsProductYield/% b
1c2-CH3C6H43-NO2BF3·OEt2(10%), 65 °C, 6 hn(3):n(4) = 1:1.35a35
2c2-CH3C6H43-NO2BF3·OEt2(20%), 65 °C, 6 hn(3):n(4) = 1:1.35a45
32-CH3C6H43-NO2BF3·OEt2(20%), 65 °C, 6 hn(3):n(4) = 1:1.35a47
42-CH3C6H43-NO2BF3·OEt2(20%), 65 °C, 8 hn(3):n(4) = 1:1.35a50
52-CH3C6H43-NO2BF3·OEt2(20%), 65 °C, 10 hn(3):n(4) = 1:1.35a53
62-CH3C6H43-NO2BF3·OEt2(20%), 65 °C, 14 hn(3):n(4) = 1:1.35a44
72-CH3C6H43-NO2BF3·OEt2(20%), 65 °C, 10 hn(3):n(4) = 1:1.55a55
82-CH3C6H42-NO2BF3·OEt2(20%), 65 °C, 10 h5b45
92-CH3C6H44-NO2BF3·OEt2(20%), 65 °C, 10 h5c49
104-CH3C6H43-NO2BF3·OEt2(20%), 65 °C, 10 h5d56
114-CH3C6H42-NO2BF3·OEt2(20%), 65 °C, 10 h5e40
124-CH3C6H44-NO2BF3·OEt2(20%), 65 °C, 10 h5f48
134-CH3OC6H43-NO2BF3·OEt2(20%), 65 °C, 10 h5g85
144-CH3OC6H42-NO2BF3·OEt2(20%), 65 °C, 10 h5h66
154-CH3OC6H44-NO2BF3·OEt2(20%), 65 °C, 10 h5i80
163-CH3OC6H43-NO2BF3·OEt2(20%), 65 °C, 10 h5j74
173-CH3OC6H42-NO2BF3·OEt2(20%), 65 °C, 10 h5k41
183-CH3OC6H44-NO2BF3·OEt2(20%), 65 °C, 10 h5l60
19C6H53-NO2BF3·OEt2(20%), 65 °C, 10 h5m52
20C6H52-NO2BF3·OEt2(20%), 65 °C, 10 h5n44
21C6H54-NO2BF3·OEt2(20%), 65 °C, 10 h5o46
22C6H5CH23-NO2BF3·OEt2(20%), 65 °C, 10 h5p56
23C6H5CH22-NO2BF3·OEt2(20%), 65 °C, 10 h5q58
24C6H5CH24-NO2BF3·OEt2(20%), 65 °C, 10 h5r65

a Unless mentioned in the table, the reaction conditions were: the mole ratio of n (3):n (4) = 1:1.5; BF3·OEt2: 20 mol % based on compound 3; Solvent: THF; Molecular sieve 4Å added; Reaction time: 10 h; Temperature: 65 °C. b Isolated yield. c Without molecular sieve 4Å.

The structures of the products were established on the basis of their spectroscopic data (IR, 1H-NMR, 13C-NMR) and elemental analysis. All compounds exhibit characteristic signals appropriately (see experimental section). This can be illustrated with compound 5a. In IR spectra, strong absorption at 1661 cm−1 corresponds to the stretching vibration of the C=O group; and absorption at 1586 and1536 cm−1 to the C=C bond. A singlet at 5.88 ppm observed in 1H-NMR spectra corresponds to OCHN proton of the benzoxazine ring. Particularly, the OCH2 protons within the benzoxazine ring absorb as two doublets at 4.74 and 4.97 ppm instead of singlet. These are characteristic signals indicating the formation of the benzoxazine ring [28]. Interestingly, the NCH2CO protons also absorb as two doublets at 3.88 and 4.13 ppm. A singlet at 2.06 ppm corresponds to CH3 protons. In 13C-NMR, a signal at 167.30 ppm corresponds to the C=O carbon, and signals at 88.59 and 64.74 ppm stand for the OCHN and OCH2 carbons, respectively. CH3 carbon absorbs at 17.37 ppm.

2.2. Fungicidal Activity Assay

According to standard method NY/T1156.5–2006 [29], the in vitro fungicidal activities of the prepared compounds 5a–r were evaluated, adopting the mycelium growth rate test method. The fungicidal activity was tested against Sclerotonia sclerotiorum, Botrytis cinerea, Rhizoctonia solani, Gibberella zeae and Phytophythora capsic at 25 µg/mL, and against Magnaporthe oryzae at 50 µg/mL. The activities were expressed as inhibition rate (%), and the results are summarized in Table 2. All compounds exhibited certain activities against the tested fungi, and some showed good activities. Compounds 5d and 5g showed 60.1% and 54.5% activity against M. oryzae, respectively, which are all higher than that of chlorothalonil (53.8%). The activity of compound 5o (51.7%) is closed to that of chlorothalonil. Compound 5i showed 71.9% activity against S. sclerotiorum at 25 µg/mL, which is close to that of chlorothalonil (84.9%). In addition, the compounds with the amide nitrogen atom connected with an aryl group were more active than those with a benzyl group. For S. sclerotiorum and R. solani, when the substituent at the 4-position of the benzene ring was connected with the amide nitrogen, the compounds with a NO2 group at the 4-position of the benzene ring exhibited higher activities than those with a NO2 group at 3- or 2-position.
Table 2

Fungicidal activities of compounds 5a–r.

Compd.S. sclerotiorum/%B. cinerea/%R. solani/%G. zeae/%P. capsici/%M. oryzae/% a
5a33.343.821.112.57.718.2
5b33.337.518.437.530.827.3
5c33.331.35.312.515.413.6
5d14.343.8 26.331.315.460.1
5e14.331.321.16.338.536.4
5f47.656.3 28.9 31.3 15.4 22.7
5g57.112.5 21.1 25.0 15.4 54.5
5h23.818.831.631.338.522.7
5i71.925.0 31.6 12.5 15.431.8
5j14.312.518.437.530.822.7
5k42.925.021.112.57.722.7
5l23.843.831.612.515.427.3
5m14.350.026.337.515.427.3
5n28.637.518.418.838.522.7
5o27.323.851.753.833.351.7
5p11.611.519.617.111.141.2
5q46.538.525.517.129.641.2
5r16.330.815.712.211.111.8
Chlorothalonil b84.992.985.267.678.653.8

a The value measured at concentration of 50 µg/mL. b Chlorothalonil used as reference compound.

3. Experimental Section

3.1. Materials and Reagents

All solvents were dried by standard procedure. Aromatic aldehydes, 2-aminobenzyl alcohol, and substituted anilines were commercially available. Infrared spectra were recorded on a Nicolet-6700 FT-IR. 1H- and 13C-NMR spectra were recorded on Bruker Avance-500 MHz spectrometer. Elemental analysis was measured on PE 2400 II CHNS instrument. Melting points were determined on a WRS-1B digital melting point instrument and uncorrected.

3.2. Chemical Synthesis

3.2.1. Synthesis of N-Substituted 2-(2-(hydroxymethyl)phenylamino)acetamides 3a–f

General Procedure: Into a 150 mL round bottom flask equipped with a condenser, N-(2-methylphenyl)-2-bromoacetamide (2.270 g, 10 mmol), 2-aminobenzyl alcohol (1.476 g, 12 mmol), potassium carbonate (1.932 g, 14 mmol) and mixed solvent of DMF and THF (45 mL, v:v = 1:2) were added with stirring. The mixture was heated at 65 °C for 12 h (checked by TLC). Then, the solvent was evaporated under reduced pressure. Saturated brine (50 mL) was added to the residue and extracted with ethyl acetate (3 × 50 mL). The organic phase was washed sequentially with water (2 × 50 mL), saturated brine (2 × 50 mL), and dried over Na2SO4, and filtered. The filtrate was evaporated under reduced pressure, the obtained residue purified by silica gel flash chromatography with ethyl acetatepetroleum ether (v/v = 1:2) as eluent, giving the product 3a (73% yield) as a white solid. N-(2-Methylphenyl)-2-(2-(hydroxymethyl)phenylamino)acetamide (3a): Yield 73%. White solid, m.p.: 115.1–118.3 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.53 (s, 1H), 7.92 (d, J = 5 Hz,1H), 7.23–7.26 (m, 2H), 7.11 (d, J = 7.5 Hz, 2H), 7.09 (t, J = 7.5 Hz, 1H),6.79 (t, J = 7.0 Hz, 1H), 6.67 (d, J = 8.0 Hz, 1H), 5.66 (s, 1H), 4.76 (d, J = 5 Hz, 2H), 3.98 (s, 2H), 2.04 (s, 1H), 1.97 (s, 3H, -CH3); 13C-NMR (125 MHz, CDCl3) δ: 168.69, 146.20, 135.26, 131.52, 130.37, 129.91, 129.24, 126.80, 125.15, 125.00, 122.20, 118.84, 111.48, 64.75, 48.89, 17.11; IR (KBr, cm−1) ν: 3309, 3257, 1670, 1585, 1541, 1264, 1011, 748. N-(4-Methylphenyl)-2-(2-(hydroxymethyl)phenylamino)acetamide (3b): Eluent: acetate/petroleum ether (v/v = 1:2); Yield 73%. White solid, m.p.: 123.4–124.5 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.51 (s, 1H), 7.33 (d, J = 8.0 Hz, 2H),7.20 (t, J = 8.0 Hz, 1H) 7.06–7.09 (m, 3H), 6.77 (t, J = 6.0 Hz, 1H), 6.58 (s, 1H), 5.52 (s, 1H), 4.72 (d, J = 5 Hz,2H), 3.86 (s, 2H), 2.28 (s,3H, -CH3); 13C-NMR (125 MHz, CDCl3) δ: 169.60, 146.40, 134.60, 134.39, 129.79, 129.48 (2C),129.41, 125.19, 120.31 (2C), 118.59, 111.30, 64.27, 48.87, 20.90; IR (KBr, cm−1) ν: 3398, 3321, 3229, 1677, 1609, 1552, 1525, 1313, 992, 818, 738. N-(4-Methyloxyphenyl)-2-(2-(hydroxymethyl)phenylamino)acetamide (3c): Eluent: acetate/petroleum ether (v/v = 1:2); Yield 68%. Pale yellow solid, m.p.: 107.0–107.2 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.59 (s, H), 7.34 (d, J = 7.0Hz, 2H), 7.20 (s, 1H), 7.08 (s, 1H), 6.76–6.80 (m, 3H), 6.56 (t, J = 5.0 Hz, 1H), 5.51 (s, 1H), 4.69 (s, 2H), 3.83 (s, 2H), 3.74 (s, 3H, -OCH3); 13C-NMR (125 MHz, CDCl3) δ: 169.38, 156.62, 146.31, 130.17, 129.68, 129.30, 125.06, 121.97, 118.46, 114.00 (2C), 111.16, 64.21, 55.36, 48.67; IR (KBr, cm−1) ν: 3399, 3298, 1669, 1609, 1507, 1453, 1300, 1236, 1000, 825, 743. N-(3-Methyloxyphenyl)-2-(2-(hydroxymethyl)phenylamino)acetamido (3d): Eluent: acetate/petroleum ether (v/v = 1:2); Yield 65%. Pale yellow solid, m.p.: 120.9–124.4 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.48 (s, 1H), 7.08–7.18 (m, 3H), 7.02 (d, J = 7.0 Hz, 1H), 6.87 (d, J = 8.0 Hz, 1H), 6.71 (t, J = 7.0 Hz, 1H), 6.56–6.58 (m, 1H), 6.52 (d, J = 8.0 Hz, 1H), 4.68 (s, 2H), 3.83 (s, 2H), 3.69 (s, 3H, -OCH3); 13C-NMR (125 MHz, CDCl3) δ: 169.36, 160.11, 146.44, 138.42, 129.96, 129.68, 129.36, 125.12, 118.83, 112.22, 111.51, 110.32, 105.85, 64.62, 55.34, 49.17; IR (KBr, cm−1) ν: 3391, 3336, 1672, 1601, 1560, 1516, 1455, 1430, 1050, 1006, 780, 749. N-Phenyl-2-(2-(hydroxymethyl)phenylamino)acetamido (3e): Eluent: acetate/petroleum ether (v/v = 1:2); Yield 70%. White solid, m.p.: 117.2–119.3 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.59 (s, 1H), 7.45 (d, J = 8.0 Hz, 2H), 7.26 (t, J = 7.5 Hz, 2H), 7.19 (td, J = 8.0 Hz, 1.0 Hz, 1H), 7.08 (t, J = 6.5 Hz, 2H), 6.77 (t, J = 7.5 Hz, 1H), 6.57(d, J = 8.0 Hz, 1H), 5.52 (br, 1H), 4.72 (s, 2H), 3.86 (s, 2H), 2.77 (br, 1H); 13C-NMR (125 MHz, CDCl3) δ: 169.61, 146.39, 137.18, 129.87, 129.41, 129.00 (2C), 125.18, 124.70, 120.20 (2C), 118.72, 111.37, 64.41, 48.98; IR (KBr, cm−1) ν: 3342, 3265, 1678, 1608, 1563, 1513, 1498, 1444, 1313, 1254, 1003, 751. N-Benzyl-2-(2-(hydroxymethyl)phenylamino)acetamido (3f): Eluent: acetate/petroleum ether (v/v = 1:2); Yield 66%. Pale yellow solid, m.p.: 107.7–108.8 °C; 1H-NMR (500 MHz, CDCl3) δ: 7.13–7.25 (m, 8H), 7.02 (d, J = 6.0 Hz, 1H), 6.73 (s, 1H, NH), 6.51 (s, 1H, NH), 4.60 (s, 2H), 4.37 (s, 2H), 3.77 (s, 2H); 13C-NMR (125 MHz, CDCl3) δ: 171.14, 146.48, 138.01, 129.63, 129.28, 128.62 (2C), 127.45 (2C), 127.41, 125.07, 118.27, 111.11, 64.35, 48.19, 43.01; IR (KBr, cm−1) ν: 3375, 3254, 1645, 1585, 1530, 1505, 1450, 1427, 1365, 1311, 1252, 1016, 751.

3.2.2. Synthesis of 2,4-Dihydro-1H-3,1-benzoxazines 5a–r

General Procedure: Under nitrogen, into a 100 mL three-necked round bottom flask equipped with a condenser, N-(2-methylphenyl)-2-(2-(hydroxymethyl)phenylamino)acetamide 3a (0.405 g, 1.5 mmol), 3-nitrobenzaldehyde (0.339 g, 2.25 mmol), THF (30 mL), BF3·OEt2 (0.031 g, 0.3 mmol) and molecular sieve 4Å (0.250 g) were added with stirring. The solution was heated at 65 °C for 10 h (checked by TLC). Then, the solvent was evaporated under reduced pressure. Ethyl acetate (70 mL) was added to the residue, and the obtained solution washed sequentially with water (2 × 40 mL) and saturated brine (2 × 40 mL). The organic phase was dried over Na2SO4 and filtered. The filtrate was evaporated under reduced pressure and the obtained residue purified by silica gel flash chromatography with ethyl acetatepetroleum ether (v/v = 1:5) as eluent, giving the product 5a (55% yield) as a yellow solid. 1-((2-Methylphenyl)carbamoylmethyl)-2-(3-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5a): Yield 55%. Yellow solid; m.p.: 151.2–152.2 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.50 (s, 1H), 8.34 (s, 1H), 8.23 (d, J = 9.0 Hz, 1H), 7.84 (d, J = 8.0 Hz, 1H), 7.78 (d, J = 7.5 Hz, 1H), 7.58 (t, J = 8.0 Hz, 1H), 7.24 (d, J = 7.0 Hz, 1H), 7.19 (t, J = 8.0 Hz, 1H), 7.13 (t, J = 7.0 Hz, 1H), 7.05 (t, J = 7.5 Hz, 1H), 6.93–6.97 (m, 3H), 5.88 (s, 1H, NCHO), 4.97 (d, J = 15 Hz, 1H), 4.74 (d, J = 15 Hz, 1H), 4.13 (d, J = 18 Hz, 1H), 3.88 (d, J = 18 Hz, 1H), 2.06 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.30 (C=O), 148.67, 141.92, 139.47, 135.04, 133.57, 130.53, 130.08, 128.70, 128.54, 126.86, 125.32, 125.09, 124.28, 122.82, 122.47, 122.23, 121.18, 115.20, 88.59, 64.74, 54.86, 17.37; IR (KBr, cm−1) ν: 3268, 1661 (C=O), 1586, 1536, 1497, 1458, 1397, 1346, 1259, 1208, 1070, 757, 733; Anal. Calcd. for C23H21N3O4: C, 68.47; H, 5.25; N, 10.42; Found: C, 68.16; H, 5.22; N, 10.37. 1-((2-Methylphenyl)carbamoylmethyl)-2-(2-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5b): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 45%. Yellow solid, m.p.: 162.6–162.9 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.51(s, 1H), 7.88 (d, J = 7.5 Hz, 1H), 7.78 (d, J = 8.0 Hz, 1H), 7.55–7.59 (m, 3H), 7.16–7.24 (m, 2H), 7.09 (d, J = 7.0 Hz, 1H), 7.03 (t, J = 7.0 Hz,1H), 6.89–6.91 (m, 3H), 6.44 (s, 1H, NCHO), 4.91 (d, J = 15 Hz, 1H), 4.61 (d, J = 15 Hz, 1H), 4.13 (d, J = 18 Hz, 1H) 3.96 (d, J = 18 Hz, 1H), 1.99 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.39 (C=O), 149.06, 141.80, 135.07, 133.07, 131.15, 130.50, 130.40, 129.34, 128.75, 128.58, 126.76, 125.24, 125.07, 125.05, 122.34, 121.99, 120.76, 114.34, 85.18, 65.30, 54.26, 17.29; IR (KBr, cm−1) ν: 3396, 2846, 1677 (C=O), 1606, 1533, 1515, 1499, 1466, 1459, 1354, 1326, 1186, 959, 759; Anal. Calcd. for C23H21N3O4: C, 68.47; H, 5.25; N, 10.42; Found: C, 68.75; H, 5.23; N, 10.38. 1-((2-Methylphenyl)carbamoylmethyl)-2-(4-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5c): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 49%. Yellow solid, m.p.: 153.4–153.8 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.47 (s, 1H), 8.24 (d, J = 8.5 Hz, 2H), 7.84 (d, J = 8.0 Hz, 1H), 7.62 (d, J = 8.5 Hz, 2H), 7.18–7.25 (m, 2H), 7.13 (d, J = 7.5 Hz, 1H), 7.06 (t, J = 7.5 Hz, 1H), 6.93–6.96 (m, 3H), 5.89 (s, 1H, NCHO), 4.94 (d, J = 15 Hz, 1H), 4.69 (d, J = 15 Hz, 1H), 4.14 (d, J = 18 Hz, 1H), 3.88 (d, J = 18 Hz, 1H), 2.03 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.28 (C=O), 148.42, 144.07, 141.68, 135.03, 130.54, 128.68 (3C), 128.50, 126.90, 125.36, 125.12, 124.15 (2C), 122.36, 122.29, 121.06, 114.90, 88.52, 64.46, 54.78, 17.39; IR (KBr, cm−1) ν: 3308, 1663 (C=O), 1608, 1585, 1531, 1502, 1459, 1354, 1291, 1257, 1080, 859, 741; Anal. Calcd. for C23H21N3O4: C, 68.47; H, 5.25; N, 10.42; Found: C, 68.15; H, 5.27; N, 10.46. 1-((4-Methylphenyl)carbamoylmethyl)-2-(3-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5d): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 56%. Yellow solid, m.p.: 168.5–169.1 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.49 (s, 1H), 8.31 (s, 1H), 8.13 (d, J = 8.0 Hz, 1H), 7.72 (d, J = 8.0 Hz, 1H), 7.49 (t, J = 8.0 Hz, 1H), 7.25 (d, J = 8.0 Hz, 2H), 7.16–7.19 (m, 1H), 7.03 (d, J = 8.0 Hz, 2H), 6.88 (d, J = 6.5 Hz, 2H), 6.85 (d, J = 6.5 Hz, 1H), 5.76 (s, 1H, NCHO), 4.96 (d, J = 15Hz, 1H), 4.72 (d, J = 15 Hz, 1H), 3.92 (d, J = 18 Hz, 1H), 3.78 (d, J = 18 Hz, 1H), 2.22 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.36 (C=O), 148.64, 142.61, 139.42, 134.48, 134.44, 133.57, 130.05, 129.57 (2C), 128.65, 124.99, 124.31, 122.80 (2C), 121.41, 119.84 (2C), 115.95, 88.81, 65.27, 55.33, 20.89; IR (KBr, cm−1) ν: 3318, 1681 (C=O), 1602, 1528, 1505, 1349, 1309, 1257, 1241, 1056, 964, 814, 739; Anal. Calcd. for C23H21N3O4: C, 68.47; H, 5.25; N, 10.42; Found: C, 68.13; H, 5.27; N, 10.48. 1-((4-Methylphenyl)carbamoylmethyl)-2-(2-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5e): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 40%. Yellow solid, m.p.: 136.0–138.5 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.65 (s, 1H), 7.81 (d, J = 8.0 Hz, 1H), 7.64 (d, J = 8.0 Hz, 1H), 7.54 (t, J = 7.5 Hz, 1H), 7.45 (t, J = 7.5 Hz, 1H), 7.27 (d, J = 8.5 Hz, 2H), 7.15–7.19 (m, 1H), 7.01 (d, J = 7.0 Hz, 2H), 6.88 (d, J = 3.5 Hz, 2H), 6.83 (d, J = 8.5 Hz, 1H), 6.28 (s, 1H, NCHO), 4.94 (d, J = 15 Hz, 1H), 4.67 (d, J = 15 Hz, 1H), 3.92 (d, J = 18 Hz, 1H), 3.86 (d, J = 18 Hz, 1H), 2.22 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.67 (C=O), 148.88, 143.17, 134.66, 134.24, 133.18, 131.02, 130.40, 129.55, 129.49 (2C), 128.47, 124.99, 124.94, 122.92, 121.42, 119.75 (2C), 116.10, 85.39, 66.14, 55.03, 20.90; IR (KBr, cm−1) ν: 3337, 2919, 1671 (C=O), 1587, 1524, 1488, 1455, 1352, 1206, 1029, 923, 738; Anal. Calcd. for C23H21N3O4: C, 68.47; H, 5.25; N, 10.42; Found: C, 68.90; H, 5.22; N, 10.36. 1-((4-Methylphenyl)carbamoylmethyl)-2-(4-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5f): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 48%. Yellow solid, m.p.: 157.2–158.5 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.53 (s, 1H), 8.22 (d, J = 8.5 Hz, 2H), 7.64 (d, J = 8.5 Hz, 2H), 7.31 (d, J = 8.5 Hz, 2H), 7.21–7.25 (m, 1H), 7.10 (d, J = 8.0 Hz, 2H), 6.93–6.95 (m, 3H), 5.85 (s, 1H, NCHO), 4.99 (d, J = 15 Hz, 1H), 4.75 (d, J = 15 Hz, 1H), 4.03 (d, J = 18Hz, 1H), 3.85 (d, J = 18 Hz, 1H), 2.30 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.38 (C=O), 148.38, 144.01, 142.34, 134.52, 134.49, 129.59 (2C), 128.66 (2C), 128.63, 125.04, 124.13 (2C), 122.78, 121.34, 119.83 (2C), 115.77, 88.68, 64.88, 55.34, 20.89; IR (KBr, cm−1) ν: 3369, 2973, 1672 (C=O), 1605, 1519, 1348, 1329, 1191, 1067, 966, 813, 745; Anal. Calcd. for C23H21N3O4: C, 68.47; H, 5.25; N, 10.42; Found: C, 68.08; H, 5.22; N, 10.47. 1-((4-Methyloxyphenyl)carbamoylmethyl)-2-(3-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5g): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 85%. Yellow solid, m.p.: 167.0–167.2 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.49 (s, 1H), 8.31 (s, 1H), 8.13 (d, J = 8.0 Hz, 1H), 7.72 (d, J = 7.5 Hz, 1H), 7.49 (t, J = 8.0 Hz, 1H), 7.25 (d, J = 7.5 Hz, 2H), 7.18 (t, J = 6.5 Hz, 1H), 7.02 (d, J = 8.0 Hz, 2H), 6.84–6.88 (m, 3H), 5.76 (s, 1H, NCHO), 4.96 (d, J = 15Hz, 1H), 4.71 (d, J = 15 Hz, 1H), 3.91 (d, J = 18 Hz, 1H), 3.77 (d, J = 18 Hz, 1H), 2.22 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.36 (C=O), 148.63, 142.62, 139.42, 134.47, 134.45, 133.59, 130.06, 129.57 (2C), 128.65, 124.99, 124.31, 122.80 (2C), 121.40, 119.84 (2C), 115.95, 88.81, 65.29, 55.32, 20.91; IR (KBr, cm−1) ν: 3319, 1682 (C=O), 1603, 1527, 1504, 1444, 1404, 1350, 1309, 1257, 1242, 1179, 1057, 965, 931, 814, 740; Anal. Calcd. for C23H21N3O5: C, 65.86; H, 5.05; N, 10.02; Found: C, 65.56; H, 5.03; N, 10.06. 1-((4-Methyloxyphenyl)carbamoylmethyl)-2-(2-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (: Eluent: acetate/petroleum ether (v/v = 1:5); Yield 66%. Yellow solid, m.p.: 156.1–158.2 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.67 (s, 1H), 7.89 (d, J = 8.0 Hz, 1H), 7.70 (d, J = 7.5 Hz, 1H), 7.62 (t, J = 7.5 Hz, 1H), 7.53 (t, J = 7.5 Hz, 1H), 7.36 (d, J = 9.0 Hz, 2H), 7.22–7.23 (m, 1H), 6.96 (d, J = 4.5 Hz, 2H), 6.92 (d, J = 8.5 Hz, 1H), 6.83 (d, J = 9.0 Hz, 2H), 6.36 (s, 1H, NCHO), 5.01 (d, J = 15 Hz, 1H), 4.74 (d, J = 15 Hz, 1H), 3.99 (d, J = 15 Hz, 1H), 3.93 (d, J = 15 Hz, 1H), 3.77 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.53 (C=O), 156.67, 148.88, 143.15, 133.17, 131.03, 130.40, 130.37, 129.56, 128.46, 124.99, 124.95, 122.89, 121.47 (2C), 121.39, 116.04, 114.14 (2C), 85.38, 66.11, 55.49, 54.93; IR (KBr, cm−1) ν: 3339, 2942, 1674 (C=O), 1605, 1531, 1506, 1465, 1405, 1346, 1316, 1246, 1175, 1038, 962, 839, 744; Anal. Calcd. for C23H21N3O5: C, 65.86; H, 5.05; N, 10.02; Found: C, 65.46; H, 5.08; N, 9.97. 1-((4-Methyloxyphenyl)carbamoylmethyl)-2-(4-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (: Eluent: acetate/petroleum ether (v/v = 1:5); Yield 80%. Pale yellow solid, m.p.: 156.6–158.5 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.42 (s, 1H), 8.16 (d, J = 8.5 Hz, 2H), 7.57 (d, J = 8.5 Hz, 2H), 7.26 (d, J = 9.0 Hz, 2H), 7.15–7.19 (m, 1H), 6.85–6.88 (m, 3H), 6.76 (d, J = 9.0 Hz, 2H), 5.78 (s, 1H, NCHO), 4.92 (d, J = 15 Hz, 1H), 4.66 (d, J = 15 Hz, 1H), 3.96 (d, J = 18 Hz, 1H), 3.78 (d, J = 18 Hz, 1H), 3.71 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.22 (C=O), 156.75, 148.39, 144.00, 142.30, 130.61, 130.13, 128.65 (2C), 125.04, 124.14 (2C), 122.72, 121.58 (2C), 121.31, 115.69, 114.25 (2C), 88.67, 64.84, 55.51, 55.24; IR (KBr, cm−1) ν: 3379, 2934, 1684 (C=O), 1601, 1523, 1494, 1347, 1307, 1264, 1240, 1039, 865, 763; Anal. Calcd. for C23H21N3O5: C, 65.86; H, 5.05; N, 10.02; Found: C, 66.24; H, 5.02; N, 10.07. 1-((3-Methyloxyphenyl)carbamoylmethyl)-2-(3-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5j): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 74%. Pale yellow solid, m.p.: 56.6–58.4 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.65 (s, 1H), 8.39 (s, 1H), 8.21 (d, J = 8.0 Hz, 1H), 7.80 (d, J = 7.5 Hz, 1H), 7.58 (t, J = 7.5 Hz, 1H), 7.18–7.26 (m, 3H), 6.92–6.97 (m, 4H), 6.66 (d, J = 8.0 Hz, 1H), 5.84 (s, 1H, NCHO), 5.04 (d, J = 15 Hz, 1H), 4.80 (d, J = 15 Hz, 1H) ,4.00 (d, J = 18 Hz, 1H), 3.85 (d, J = 18 Hz, 1H), 3.79 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.60 (C=O), 160.17, 148.62, 142.57, 139.36, 138.21, 133.62, 130.13, 129.83, 128.70, 125.05, 124.37, 122.87, 122.79, 121.55, 116.09, 111.87, 110.61, 105.41, 88.81, 65.29, 55.50, 55.39; IR (KBr, cm−1) ν: 3327, 3078, 2937, 2837, 1674 (C=O), 1606, 1530, 1494, 1458, 1349, 1290, 1220, 1155, 1085, 1046, 960, 754; Anal. Calcd. for C23H21N3O5: C, 65.86; H, 5.05; N, 10.02; Found: C, 65.52; H, 5.07; N, 9.98. 1-((3-Methyloxyphenyl)carbamoylmethyl)-2-(2-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5k): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 41%. Brown yellow solid, m.p.: 50.9–52.4 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.73 (s, 1H), 7.80 (d, J = 8.0 Hz, 1H), 7.64 (d, J = 8.0 Hz, 1H), 7.54 (t, J = 7.5 Hz, 1H), 7.44 (t, J = 8.0 Hz, 1H), 7.18 (s, 1H), 7.12–7.15 (m, 2H), 7.09 (d, J = 8.0 Hz, 1H), 6.86–6.88 (m, 2H), 6.83 (d, J = 8.0 Hz, 1H), 6.57 (d, J = 8.0 Hz, 1H), 6.27 (s, 1H, NCHO), 4.94 ( d, J = 15 Hz, 1H), 4.67 (d, J = 15 Hz, 1H), 3.87 (d, J = 5 Hz, 2H), 3.70 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 168.00 (C=O), 160.12, 148.84, 143.23, 138.40, 133.26, 130.98, 130.46, 129.73, 129.60, 128.50, 125.03, 124.99, 123.06, 121.59, 116.31, 111.88, 110.44, 105.38, 85.44, 66.21, 55.36, 55.19; IR (KBr, cm−1) ν: 3361, 2974, 2895, 1680 (C=O), 1607, 1532, 1494, 1457, 1377, 1088, 1049, 881, 753; Anal. Calcd. for C23H21N3O5: C, 65.86; H, 5.05; N, 10.02; Found: C, 65.55; H, 5.03; N, 10.06. 1-((3-methyloxyphenyl)carbamoylmethyl)-2-(4-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5l): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 60%. Yellow solid, m.p.: 128.7–129.9 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.54 (s, 1H), 8.14 (d, J = 8.5 Hz, 2H),7.56(d,J =8.5 Hz, 2H), 7.13–7.18 (m, 2H), 7.10 (d, J = 8.0 Hz, 1H), 6.81–6.87 (m, 4H), 6.58 (td, J = 8.0, 2.0 Hz, 1H), 5.78 (s, 1H, NCHO), 4.92 (d, J = 15 Hz, 1H), 4.67 (d, J = 15 Hz, 1H), 3.96 (d, J = 18 Hz, 1H), 3.78 (d, J = 18 Hz, 1H) ,3.70 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ: 167.63 (C=O), 160.20, 148.35, 143.99, 142.30, 138.30, 129.80, 128.67 (2C), 128.62, 125.07, 124.13 (2C), 122.85, 121.40, 115.86, 111.85, 110.39, 105.64, 88.65, 64.88, 55.44, 55.35; IR (KBr, cm−1) ν: 3366, 1666 (C=O), 1602, 1593, 1520, 1456, 1434, 1348, 1330, 1270, 1157, 1073, 1052, 972, 855, 776; Anal. Calcd. for C23H21N3O5: C, 65.86; H, 5.05; N, 10.02; Found: C, 66.15; H, 5.03; N, 9.99. 2-(3-Nitrophenyl)-1-(phenylcarbamoylmethyl)-2,4-dihydro-1H-3,1-benzoxazine (5m): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 52%. Yellow solid, m.p.: 130.6–131.5 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.59 (s, 1H), 8.35 (s, 1H), 8.18 (d, J = 8.0 Hz, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.53 (t, J = 8.0 Hz, 2H), 7.42 (d, J = 8.0 Hz, 2H), 7.27 (t, J = 7.5 Hz, 2H), 7.19–7.23 (m, 1H), 7.08 (t, J = 7.5 Hz, 1H), 6.90–6.94 (m, 2H), 5.81 (s, 1H, NCHO), 5.01 (d, J = 15 Hz, 1H), 4.76 (d, J = 15 Hz, 1H), 3.99 (d, J = 18 Hz, 1H), 3.84 (d, J = 15 Hz, 1H); 13C-NMR (125 MHz, CDCl3) δ: 167.61 (C=O), 148.68, 142.59, 139.42, 137.05, 133.61, 130.11, 129.14 (2C), 128.71, 125.06, 124.83, 124.35, 122.89, 122.83, 121.52, 119.83 (2C), 116.05, 88.84, 65.27, 55.44; IR (KBr, cm−1) ν: 3302, 3069, 1669 (C=O), 1602, 1532, 1496, 1444, 1349, 1301, 1256, 1174, 1079, 751; Anal. Calcd. for C22H19N3O4: C, 67.86; H, 4.92; N, 10.79; Found: C, 67.59; H, 4.90; N, 10.75. 2-(2-Nitrophenyl)-1-(phenylcarbamoylmethyl)-2,4-dihydro-1H-3,1-benzoxazine (5n): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 44%. Yellow solid, m.p.: 157.5–158.8 °C; 1H-NMR (500 MHz, CDCl3), δ: 8.73 (s, 1H), 7.80 (d, J = 8.5 Hz, 1H), 7.64 (d, J = 8.0 Hz, 1H), 7.53 (t, J = 7.5 Hz, 1H), 7.44 (t, J = 7.5 Hz, 1H), 7.39 (d, J = 8.0 Hz, 2H), 7.18–7.23 (m, 2H), 7.12–7.14 (m, 1H), 7.02 (t, J = 7.5 Hz, 1H), 6.86 (d, J = 4.5 Hz, 2H), 6.84 (d, J = 8.0 Hz, 1H), 6.28 (s, 1H, NCHO), 4.95 (d, J = 15 Hz, 1H), 4.67 (d, J = 15 Hz, 1H), 3.93 (d, J = 18 Hz, 1H), 3.88 (d, J = 18 Hz, 1H); 13C-NMR (125 MHz, CDCl3) δ: 167.95 (C=O), 148.91, 143.17, 137.25, 133.23, 131.01, 130.46, 129.61, 129.05 (2C), 128.52, 125.02 (2C), 124.63, 123.00, 121.53, 119.76 (2C), 116.18, 85.46, 66.16, 55.13; IR (KBr, cm−1) ν: 3316, 3207, 1676 (C=O), 1603, 1553, 1528, 1495, 1441, 1346, 1311, 1252, 1197, 1075, 750; Anal. Calcd. for C22H19N3O4: C, 67.86; H, 4.92; N, 10.79; Found: C, 67.54; H, 4.90; N, 10.74. 2-(4-Nitrophenyl)-1-(phenylcarbamoylmethyl)-2,4-dihydro-1H-3,1-benzoxazine (5o): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 46%. Yellow solid, m.p.: 142.6–144.0 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.66 (s, 1H), 8.22 (d, J = 8.5 Hz, 2H), 7.64 (d, J = 8.5 Hz, 2H), 7.44 (d, J = 7.5 Hz, 2H), 7.30 (t, J = 8.0 Hz, 2H), 7.21–7.25 (m, 1H), 7.12 (t, J = 7.5 Hz, 1H), 6.92–6.95 (m, 3H), 5.86 (s, 1H, NCHO), 5.01 (d, J = 15 Hz, 1H), 4.75 (d, J = 15 Hz, 1H), 4.05 (d, J = 18 Hz, 1H), 3.86 (d, J = 18Hz, 1H); 13C-NMR (125 MHz, CDCl3) δ: 167.56 (C=O), 148.46, 143.99, 142.29, 137.10, 129.19 (2C), 128.73, 128.70 (2C), 125.13, 124.88, 124.23 (2C), 122.87, 121.51, 119.79 (2C), 115.91, 88.75, 64.90, 55.52; IR (KBr, cm−1) ν: 3365, 1666 (C=O), 1600, 1519, 1444, 1350, 1331, 1263, 853, 762; Anal. Calcd. for C22H19N3O4: C, 67.86; H, 4.92; N, 10.79; Found: C, 67.55; H, 4.94; N, 10.83. 1-(Benzylcarbamoylmethyl)-2-(3-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5p): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 56%. Yellow solid, m.p.: 103.3–105.7 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.28 (s, 1H), 8.20 (d, J = 8.0 Hz, 1H), 7.68 (d, J = 7.5 Hz, 1H), 7.48 (t, J = 8.0 Hz, 1H), 7.22–7.26 (m, 4H), 7.15 (s, 1H), 7.07–7.09 (m, 2H), 6.92–6.93 (m, 2H), 6.85 (d, J = 8.0 Hz, 1H), 5.75 (s, 1H, NCHO), 4.91 (d, J = 15 Hz, 1H), 4.69 (d, J = 15 Hz, 1H), 4.49 (dd, J = 14.5, 6.0 Hz, 1H), 4.32 (dd, J = 14.5, 5.0 Hz, 1H), 3.95 (d, J = 18 Hz, 1H), 3.78 (d, J = 18 Hz, 1H); 13C-NMR (125 MHz, CDCl3) δ: 169.25 (C=O), 148.56, 142.52, 139.52, 137.69, 133.65, 130.00, 128.75 (2C), 128.53, 127.62, 127.56 (2C), 124.96, 124.26, 122.85, 122.47, 120.96, 115.43, 88.80, 65.24, 54.46, 43.37; IR (KBr,cm-1) ν: 3329, 1650 (C=O), 1530, 1494, 1459, 1426, 1353, 1328, 1248, 1084, 744; Anal. Calcd. for C23H21N3O4: C, 68.47; H, 5.25; N, 10.42; Found: C, 68.09; H, 5.22; N, 10.37. 1-(Benzylcarbamoylmethyl)-2-(2-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5q): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 58%. Yellow solid, m.p.: 96.2–97.3 °C; 1H-NMR (500 MHz, CDCl3) δ: 7.82 (s, 1H), 7.47–7.53 (m, 3H), 7.21–7.25 (m, 4H), 7.05 (d, J = 4.5 Hz, 2H), 6.88–6.91 (m, 2H), 6.84 (d, J = 8.0 Hz, 1H), 6.32 (s, 1H, NCHO), 4.84 (d, J = 15.0 Hz, 1H), 4.57 (d, J = 15.0 Hz, 1H), 4.52 (dd, J = 15.0, 7.0 Hz, 1H), 4.27 (dd, J = 15.0, 5.0 Hz, 1H), 4.03 (d, J = 18.0 Hz, 1H), 3.89 (d, J = 18.0 Hz, 1H); 13C-NMR (125 MHz, CDCl3) δ: 169.42 (C=O), 148.95, 142.46, 137.84, 133.02, 131.15, 130.24, 129.46, 128.64 (2C), 128.39, 127.49 (2C), 127.41, 124.91 (2C), 122.20, 120.67, 114.97, 85.14, 65.48, 54.20, 43.18; IR (KBr, cm−1) ν: 3394, 1675 (C=O), 1607, 1530, 1501, 1466, 1358, 1325, 1263, 1188, 1067, 960, 847, 755; Anal. Calcd. for C23H21N3O4: C, 68.47; H, 5.25; N, 10.42; Found: C, 68.13; H, 5.23; N, 10.38. 1-(Benzylcarbamoylmethyl)-2-(4-nitrophenyl)-2,4-dihydro-1H-3,1-benzoxazine (5r): Eluent: acetate/petroleum ether (v/v = 1:5); Yield 65%. Yellow solid, m.p.: 147.7–148.5 °C; 1H-NMR (500 MHz, CDCl3) δ: 8.03 (d, J = 8.5 Hz, 2H), 7.45 (d, J = 8.5 Hz, 2H), 7.14–7.20 (m, 4H), 7.05 (br, 1H, NH), 6.99–7.01 (m, 2H), 6.82–6.85 (m, 2H), 6.77 (d, J = 8.5 Hz, 1H), 5.67 (s, 1H, NCHO), 4.81 (d, J = 15 Hz, 1H), 4.59 (d, J = 15 Hz, 1H), 4.4 (dd, J = 15.0, 7.0 Hz, 1H), 4.22 (dd, J = 15.0, 5.0 Hz, 1H), 3.86 (d, J = 18.0 Hz, 1H), 3.69 (d, J = 18.0 Hz, 1H); 13C-NMR (125 MHz, CDCl3) δ: 169.15 (C=O), 148.31, 144.11, 142.51, 137.75, 128.72 (2C), 128.67 (2C), 128.48, 127.69, 127.62 (2C), 124.95, 124.06 (2C), 122.49, 120.89, 115.33, 88.78, 65.06, 54.52, 43.32; IR (KBr, cm−1) ν: 3405, 1681 (C=O), 1604, 1518, 1495, 1463, 1425, 1347, 1298, 1074, 1027, 857, 761; Anal. Calcd. for C23H21N3O4: C, 68.47; H, 5.25; N, 10.42; Found: C, 68.20; H, 5.23; N, 10.39.

3.3. Fungicidal Activity Testing

The in vitro inhibition of mycelium in the agar culture medium caused by the title compounds against six phytopathogenic fungi: Sclerotonia sclerotiorum, Botrytis cinerea, Rhizoctonia solani, Gibberella zeae, Phytophythora capsic and Magnaporthe oryzae was performed. Referring to the standard method NY/T1156.5–2006, antifungal activity assays adopted the mycelium growth rate test method. Chlorothalonil was used as a reference compound. A stock solution of every test compound was prepared in acetone and then diluted to the required test concentrations (500 µg/mL) with sorporl-144 (concentration: 200 µg/mL). Solutions of the test compounds (1 mL) were added to potato dextrose agar (PDA) medium (9 mL, 45 °C) to provide the final concentration of 25 µg/mL, but 50 µg/mL for Magnaporthe oryzae. The mixed medium without sample was used as the blank control. The inocula, 4 mm in diameter, were removed from the margins of actively growing colonies of mycelium and placed in the centers of the above plates. 4 replicates were performed per treatment. Percentages of growth inhibition were calculated by comparing the mean value of the diameters of the mycelia in the test plates after placement in a 24 °C biochemical incubator thermostat for 3 days. The inhibition percent was calculated according to the following equation: where I is the inhibition rate, D1 is the average diameter of mycelia the blank test, and D0 is the average diameter of mycelia in the presence of compounds. The results are given in Table 2.

4. Conclusions

In summary, we have prepared a series of novel 1-(carbamoylmethyl)-2-aryl-3,1-benzoxazines by aza-acetalizations of 2-(N-substituted carbamoylmethylamino)benzyl alcohols with aromatic aldehydes in the presence of BF3·OEt2. The fungicidal activities of the prepared compounds against plant fungi were preliminarily evaluated, and some compounds showed good activities. Compounds 5d and 5g showed higher activity against M. Oryzae than chlorothalonil. The activity of compound 5i against S. Sclerotiorum is close to that of chlorothalonil.
  21 in total

1.  Synthesis, structure-activity relationships studies of benzoxazinone derivatives as α-chymotrypsin inhibitors.

Authors:  Bishnu P Marasini; Fazal Rahim; Shahnaz Perveen; Aneela Karim; Khalid Mohammed Khan; M Iqbal Choudhary
Journal:  Bioorg Chem       Date:  2017-01-04       Impact factor: 5.275

2.  RXR-LXR heterodimer modulators for the potential treatment of dyslipidemia.

Authors:  Bharat Lagu; Barbara Pio; Rimma Lebedev; Maria Yang; Patricia D Pelton
Journal:  Bioorg Med Chem Lett       Date:  2007-01-24       Impact factor: 2.823

3.  4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents.

Authors:  Franck Charmantray; Martine Demeunynck; Danièle Carrez; Alain Croisy; Amélie Lansiaux; Christian Bailly; Pierre Colson
Journal:  J Med Chem       Date:  2003-03-13       Impact factor: 7.446

4.  Synthesis and antihypertensive activity of 4'-substituted spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-ones.

Authors:  R D Clark; J M Caroon; A F Kluge; D B Repke; A P Roszkowski; A M Strosberg; S Baker; S M Bitter; M D Okada
Journal:  J Med Chem       Date:  1983-05       Impact factor: 7.446

5.  Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists.

Authors:  Stephen Hanessian; Thomas Jennequin; Nicolas Boyer; Vincent Babonneau; Udaykumar Soma; Clotilde Mannoury la Cour; Mark J Millan; Guillaume De Nanteuil
Journal:  ACS Med Chem Lett       Date:  2014-02-13       Impact factor: 4.345

6.  Hypervalent iodine-mediated oxygenation of N,N-diaryl tertiary amines: intramolecular functionalization of sp3 C-H bonds adjacent to nitrogen.

Authors:  Ningning Zhang; Ran Cheng; Daisy Zhang-Negrerie; Yunfei Du; Kang Zhao
Journal:  J Org Chem       Date:  2014-10-15       Impact factor: 4.354

7.  Palladium-catalyzed highly regio- and stereoselective synthesis of 4-alkylidene-4H-3,1-benzoxazines from N-acyl-o-alkynylanilines.

Authors:  Takao Saito; Shohei Ogawa; Naoya Takei; Noriki Kutsumura; Takashi Otani
Journal:  Org Lett       Date:  2011-02-03       Impact factor: 6.005

8.  Synthesis and anti-proliferative activity of a small library of 7-substituted 5H-pyrrole [1,2-a][3,1]benzoxazin-5-one derivatives.

Authors:  Mariateresa Badolato; Gabriele Carullo; Biagio Armentano; Salvatore Panza; Rocco Malivindi; Francesca Aiello
Journal:  Bioorg Med Chem Lett       Date:  2017-05-15       Impact factor: 2.823

9.  Potent nonsteroidal progesterone receptor agonists: synthesis and SAR study of 6-aryl benzoxazines.

Authors:  Puwen Zhang; Eugene A Terefenko; Andrew Fensome; Zhiming Zhang; Yuan Zhu; Jeffrey Cohen; Richard Winneker; Jay Wrobel; John Yardley
Journal:  Bioorg Med Chem Lett       Date:  2002-03-11       Impact factor: 2.823

10.  Modulating Mineralocorticoid Receptor with Non-steroidal Antagonists. New Opportunities for the Development of Potent and Selective Ligands without Off-Target Side Effects.

Authors:  Mercedes Martín-Martínez; Felipe L Pérez-Gordillo; Diego Álvarez de la Rosa; Yoel Rodríguez; Guillermo Gerona-Navarro; Rosario González-Muñiz; Ming-Ming Zhou
Journal:  J Med Chem       Date:  2017-01-24       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.